Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005308
Filing Date
2024-11-14
Accepted
2024-11-14 17:05:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 greatpoint-vtgn093024a2.htm SC 13G/A 113525
  Complete submission text file 0001172661-24-005308.txt   115287
Mailing Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830
Business Address 165 MASON STREET, 3RD FLOOR GREENWICH CT 06830 203 971-3300
GREAT POINT PARTNERS LLC (Filed by) CIK: 0001281446 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Subject) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-86249 | Film No.: 241464109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)